These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
3. Rapid signalling pathway activation by androgens in epithelial and stromal cells. Castoria G; Lombardi M; Barone MV; Bilancio A; Di Domenico M; De Falco A; Varricchio L; Bottero D; Nanayakkara M; Migliaccio A; Auricchio F Steroids; 2004 Aug; 69(8-9):517-22. PubMed ID: 15288763 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK. Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470 [TBL] [Abstract][Full Text] [Related]
5. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052 [TBL] [Abstract][Full Text] [Related]
6. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
7. Androgens activate mitogen-activated protein kinase via epidermal growth factor receptor/insulin-like growth factor 1 receptor in the mouse PC-1 cell line. Hamzeh M; Robaire B J Endocrinol; 2011 Apr; 209(1):55-64. PubMed ID: 21220406 [TBL] [Abstract][Full Text] [Related]
8. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors. Auricchio F; Migliaccio A; Castoria G Steroids; 2008 Oct; 73(9-10):880-4. PubMed ID: 18342899 [TBL] [Abstract][Full Text] [Related]
9. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. Castoria G; Lombardi M; Barone MV; Bilancio A; Di Domenico M; Bottero D; Vitale F; Migliaccio A; Auricchio F J Cell Biol; 2003 May; 161(3):547-56. PubMed ID: 12743104 [TBL] [Abstract][Full Text] [Related]
10. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Kraus S; Gioeli D; Vomastek T; Gordon V; Weber MJ Cancer Res; 2006 Nov; 66(22):11047-54. PubMed ID: 17108144 [TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells. Xie Y; Wolff DW; Lin MF; Tu Y Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995 [TBL] [Abstract][Full Text] [Related]
12. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
13. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells. Mukherjee B; Mayer D Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894 [TBL] [Abstract][Full Text] [Related]
14. Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells. Ding Y; Wang X; Xu A; Xu X; Tian K; Young CY; Yuan H J Cell Biochem; 2011 Mar; 112(3):818-28. PubMed ID: 21328455 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase. Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905 [TBL] [Abstract][Full Text] [Related]
17. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation. Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Murthy S; Agoulnik IU; Weigel NL Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350 [TBL] [Abstract][Full Text] [Related]
19. Nongenomic activity of ligands in the association of androgen receptor with SRC. Kim SB; Kanno A; Ozawa T; Tao H; Umezawa Y ACS Chem Biol; 2007 Jul; 2(7):484-92. PubMed ID: 17602621 [TBL] [Abstract][Full Text] [Related]
20. Detection of ligand-selective interactions of the human androgen receptor by SELDI-MS-TOF. Linke T; Scholten M; Baniahmad A Methods Mol Biol; 2011; 776():225-51. PubMed ID: 21796530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]